MedTrace Logo

Rebreathing of Carbon Dioxide With a Device Used for Giving Inhalational Anaesthesia

NCT01339013 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2014-09-25

Study results available
· View outcomes & findings →

Summary

The anesthesia gas reflector (AnaConDa) is built on the adsorptive capacity of active carbon which also adsorbs carbon dioxide in exhaled air. Rebreathing of carbon dioxide thus occurs and must be compensated for by increased ventilation. This study aims at determining how much compensation must be given, based on the hypothesis that rebreathing depends on carbon dioxide level in blood and exhaled air.

Conditions

  • Anesthetic Ventilatory Requirements

Interventions

DEVICE

Anesthetic Conserving Device (AnaConDa )

Standard HME was replaced by AnaConDa. AnaConDa has charcoal filter, HME does not.

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Mikael Bodelsson, Professor · Division of Surgery, Department of Anaesthesia, Skane University Hospital, Lund, Sweden

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01339013 on ClinicalTrials.gov